The combination of gemcitabine and ginsenoside Rh2 enhances the immune function of dendritic cells against pancreatic cancer via the CARD9-BCL10-MALT1 / NF-κB pathway

The combination of gemcitabine and ginsenoside Rh2 enhances the immune function of dendritic cells against pancreatic cancer via the CARD9-BCL10-MALT1 / NF-κB pathway

Copyright © 2022 Elsevier Inc. All rights reserved.

Détails bibliographiques
Publié dans:Clinical immunology (Orlando, Fla.). - 1999. - 248(2023) vom: 25. März, Seite 109217
Auteur principal: Li, Qing (Auteur)
Autres auteurs: He, Jialuo, Li, Senlin, Tian, Cheng, Yang, Jian, Yuan, Huimin, Lu, Yi, Fagone, Paolo, Nicoletti, Ferdinando, Xiang, Ming
Format: Article en ligne
Langue:English
Publié: 2023
Accès à la collection:Clinical immunology (Orlando, Fla.)
Sujets:Journal Article Research Support, Non-U.S. Gov't CARD9-BCL10-MALT1/ NF-κB pathway Dendritic cell Gemcitabine Ginsenoside Rh2 Pancreatic cancer Tumor immune microenvironment NF-kappa B ginsenoside Rh2 plus... 78214-33-2 Bcl10 protein, mouse B-Cell CLL-Lymphoma 10 Protein Malt1 protein, mouse EC 3.4.22.- Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein Card9 protein, mouse CARD Signaling Adaptor Proteins
Accès en ligne Volltext